Canada Pension Plan Investment Board Novo Nordisk A S Transaction History

Canada Pension Plan Investment Board

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$102.55 - $135.33 $3.6 Million - $4.75 Million	35,100 New	35,100 $4.75 Million
Q3 2019 Nov 12, 2019	SELL	$47.54 - $53.43 $1.93 Million - $2.17 Million	-40,565 Closed	0 $0
Q2 2019 Aug 12, 2019	SELL	$46.79 - $52.47 $3.51 Million - $3.93 Million	-74,935 Reduced 64.88%	40,565 $2.07 Million
Q1 2019 May 15, 2019	SELL	$46.36 - $52.63 $2.29 Million - $2.61 Million	-49,500 Reduced 30.0%	115,500 $6.04 Million
Q4 2018 Feb 06, 2019	BUY	$41.54 - $47.25 $5.02 Million - $5.71 Million	120,800 Added 273.3%	165,000 $7.6 Million
Q3 2018 Nov 09, 2018	SELL	$46.76 - $51.24 $4.29 Million - $4.7 Million	-91,800 Reduced 67.5%	44,200 $2.08 Million
Q2 2018 Aug 07, 2018	BUY	$44.29 - $50.42 $930,090 - $1.06 Million	21,000 Added 18.26%	136,000 $6.27 Million
Q1 2018 May 14, 2018	BUY	$48.49 - $58.14 $5.58 Million - $6.69 Million	115,000 New	115,000 $5.66 Million
Q4 2017 Feb 14, 2018	SELL	$47.53 - $53.73 $46.5 Million - $52.6 Million	-978,800 Closed	0 $0
Q3 2017 Oct 30, 2017	BUY	$41.15 - $49.22 $5.65 Million - $6.76 Million	137,300 Added 16.32%	978,800 $47.1 Million
Q1 2017 Jan 31, 2018	BUY	N/A	841,500	841,500 $28.8 Million

1,955

318M

5.49M

7.78M

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $193B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

Get notified when there are updates to the investment portfolio of Canada Pension Plan Investment Board, based on Form 13F filings with the SEC.

Stay updated on Canada Pension Plan Investment Board with notifications on news.